An NZW-derived interval on chromosome 7 moderates sialadenitis, but not insulitis in congenic nonobese diabetic mice

Journal of Immunology

Volumn 184, Issue 2, 2010, Pages 859-868

  Burt, Rachel A ^a   Watkins, Laura ^a   Tan, Iris K L ^a,b   Wang, Nancy ^a,b   Quirk, Fiona ^a   Mackin, Leanne ^b   Morgan, Phillip ^a   Zhang, Jian Guo ^a   Berzins, Stuart P ^a   Morahan, Grant ^c,d   Brodnicki, Thomas C ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; PROTEIN; SSIAL3 PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CHROMOSOME 7; CONGENIC STRAIN; CONTROLLED STUDY; FEMALE; GENE LOCUS; INSULIN DEPENDENT DIABETES MELLITUS; INSULITIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; PRIORITY JOURNAL; SALIVA ANALYSIS; SALIVARY GLAND DISEASE; SIALOADENITIS; SJOEGREN SYNDROME; TISSUE SPECIFICITY; ANIMAL; BIOSYNTHESIS; CHROMOSOME; CHROMOSOME MAP; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETICS; PATHOLOGY;

ANIMALS; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; CHROMOSOME MAPPING; CHROMOSOMES; DIABETES MELLITUS, TYPE 1; GENETIC PREDISPOSITION TO DISEASE; LINKAGE (GENETICS); MICE; MICE, CONGENIC; MICE, INBRED NOD; SIALADENITIS;

EID: 76249132465     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0903149     Document Type: Article

References (62)

1. Makino, S., K. Kunimoto, Y. Muraoka, Y. Mizushima, K. Katagiri, and Y. Tochino. 1980. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29: 1-13. (Pubitemid 10185796)
2. Serreze, D. V., and E. H. Leiter. 2001. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr. Dir. Autoimmun. 4: 31-67.
3. Robinson, C. P., H. Yamamoto, A. B. Peck, and M. G. Humphreys-Beher. 1996. Genetically programmed development of salivary gland abnormalities in the NOD (nonobese diabetic)-scid mouse in the absence of detectable lymphocytic infiltration: a potential trigger for sialoadenitis of NOD mice. Clin. Immunol. Immunopathol. 79: 50-59.
4. Robinson, C. P., S. Yamachika, C. E. Alford, C. Cooper, E. L. Pichardo, N. Shah, A. B. Peck, and M. G. Humphreys-Beher. 1997. Elevated levels of cysteine protease activity in saliva and salivary glands of the nonobese diabetic (NOD) mouse model for Sjögren syndrome. Proc. Natl. Acad. Sci. U.S.A. 94: 5767-5771.
5. Kong, L., C. P. Robinson, A. B. Peck, N. Vela-Roch, K. M. Sakata, H. Dang, N. Talal, and M. G. Humphreys-Beher. 1998. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin. Exp. Rheumatol. 16: 675-681.
6. Cha, S., S. C. van Blockland, M. A. Versnel, F. Homo-Delarche, H. Nagashima, J. Brayer, A. B. Peck, and M. G. Humphreys-Beher. 2001. Abnormal organogenesis in salivary gland development may initiate adult onset of autoimmune exocrinopathy. Exp. Clin. Immunogenet. 18: 143-160.
7. Jonsson, M. V., N. Delaleu, and R. Jonsson. 2007. Animal models of Sjögren's syndrome. Clin. Rev. Allergy Immunol. 32: 215-224.
8. Johansson, A. C., A. K. Lindqvist, M. Johannesson, and R. Holmdahl. 2003. Genetic heterogeneity of autoimmune disorders in the nonobese diabetic mouse. Scand. J. Immunol. 57: 203-213.
9. Lang, J., and D. Bellgrau. 2004. Animal models of type 1 diabetes: genetics and immunological function. Adv. Exp. Med. Biol. 552: 91-116.
10. Leiter, E. H. 2005. Nonobese diabetic mice and the genetics of diabetes susceptibility. Curr. Diab. Rep. 5: 141-148.
11. Hamilton-Williams, E. E., D. V. Serreze, B. Charlton, E. A. Johnson, M. P. Marron, A. Mullbacher, and R. M. Slattery. 2001. Transgenic rescue implicates β2-microglobulin as a diabetes susceptibility gene in nonobese diabetic (NOD) mice. Proc. Natl. Acad. Sci. U.S.A. 98: 11533-11538.
12. Ueda, H., J. M. Howson, L. Esposito, J. Heward, H. Snook, G. Chamberlain, D. B. Rainbow, K. M. Hunter, A. N. Smith, G. Di Genova, et al. 2003. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423: 506-511.
13. Kissler, S., P. Stern, K. Takahashi, K. Hunter, L. B. Peterson, and L. S. Wicker. 2006. In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes. Nat. Genet. 38: 479-483.
14. Yamanouchi, J., D. Rainbow, P. Serra, S. Howlett, K. Hunter, V. E. Garner, A. Gonzalez-Munoz, J. Clark, R. Veijola, R. Cubbon, et al. 2007. Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity. Nat. Genet. 39: 329-337.
15. Razavi, R., Y. Chan, F. N. Afifiyan, X. J. Liu, X. Wan, J. Yantha, H. Tsui, L. Tang, S. Tsai, P. Santamaria, et al. 2006. TRPV1+ sensory neurons control β cell stress and islet inflammation in autoimmune diabetes. Cell 127: 1123-1135.
16. Hung, M. S., P. Avner, and U. C. Rogner. 2006. Identification of the transcription factor Arntl2 as a candidate gene for the type 1 diabetes locus Idd6. Hum. Mol. Genet. 15: 2732-2742.
17. Laloraya, M., A. Davoodi-Semiromi, G. P. Kumar, M. McDuffie, and J. X. She. 2006. Impaired Crkl expression contributes to the defective DNA binding of Stat5b in nonobese diabetic mice. Diabetes 55: 734-741.
18. Boulard, O., G. Fluteau, L. Eloy, D. Damotte, P. Bedossa, and H. J. Garchon. 2002. Genetic analysis of autoimmune sialadenitis in nonobese diabetic mice: a major susceptibility region on chromosome 1. J. Immunol. 168: 4192-4201. (Pubitemid 34298428)
19. Brayer, J., J. Lowry, S. Cha, C. P. Robinson, S. Yamachika, A. B. Peck, and M. G. Humphreys-Beher. 2000. Alleles from chromosomes 1 and 3 of NOD mice combine to influence Sjögren's syndrome-like autoimmune exocrinopathy. J. Rheumatol. 27: 1896-1904. (Pubitemid 30670483)
20. Cha, S., H. Nagashima, V. B. Brown, A. B. Peck, and M. G. Humphreys-Beher. 2002. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background. Arthritis Rheum. 46: 1390-1398.
21. Johansson, A. C., B. Nakken, M. Sundler, A. K. Lindqvist, M. Johannesson, M. Alarcón-Riquelme, A. I. Bolstad, M. G. Humphreys-Beher, R. Jonsson, K. Skarstein, et al. 2002. The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross. Eur. J. Immunol. 32: 243-250.
22. Brodnicki, T. C., A. L. Fletcher, D. G. Pellicci, S. P. Berzins, P. McClive, F. Quirk, K. E. Webster, H. S. Scott, R. L. Boyd, D. I. Godfrey, et al. 2005. Localization of Idd11 is not associated with thymus and nkt cell abnormalities in NOD mice. Diabetes 54: 3453-3457.
23. Lyons, P. A., W. W. Hancock, P. Denny, C. J. Lord, N. J. Hill, N. Armitage, T. Siegmund, J. A. Todd, M. S. Phillips, J. F. Hess, et al. 2000. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137. Immunity 13: 107-115.
24. Hjelmervik, T. O., A. K. Lindqvist, K. Petersen, M. Johannesson, A. K. Stavrum, A. Johansson, R. Jonsson, R. Holmdahl, and A. I. Bolstad. 2007. The influence of the NOD Nss1/Idd5 loci on sialadenitis and gene expression in salivary glands of congenic mice. Arthritis Res. Ther. 9: R99.
25. Ghosh, S., S. M. Palmer, N. R. Rodrigues, H. J. Cordell, C. M. Hearne, R. J. Cornall, J. B. Prins, P. McShane, G. M. Lathrop, L. B. Peterson, et al. 1993. Polygenic control of autoimmune diabetes in nonobese diabetic mice. Nat. Genet. 4: 404-409.
26. McAleer, M. A., P. Reifsnyder, S. M. Palmer, M. Prochazka, J. M. Love, J. B. Copeman, E. E. Powell, N. R. Rodrigues, J. B. Prins, D. V. Serreze, et al. 1995. Crosses of NOD mice with the related NON strain. A polygenic model for IDDM. Diabetes 44: 1186-1195.
27. Gonzalez, A., J. D. Katz, M. G. Mattei, H. Kikutani, C. Benoist, and D. Mathis. 1997. Genetic control of diabetes progression. Immunity 7: 873-883.
28. McDuffie, M. 2000. Derivation of diabetes-resistant congenic lines from the nonobese diabetic mouse. Clin. Immunol. 96: 119-130.
29. Chen, J., P. C. Reifsnyder, F. Scheuplein, W. H. Schott, M. Mileikovsky, S. Soodeen-Karamath, A. Nagy, M. H. Dosch, J. Ellis, F. Koch-Nolte, and E. H. Leiter. 2005. "Agouti NOD": identification of a CBA-derived Idd locus on Chromosome 7 and its use for chimera production with NOD embryonic stem cells. Mamm. Genome 16: 775-783.
30. Kelley, V. E., and A. Winkelstein. 1980. Age- and sex-related glomerulonephritis in New Zealand white mice. Clin. Immunol. Immunopathol. 16: 142-150.
31. Kotzin, B. L., and E. Palmer. 1987. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice. J. Exp. Med. 165: 1237-1251.
32. Dietrich, W., H. Katz, S. E. Lincoln, H. S. Shin, J. Friedman, N. C. Dracopoli, and E. S. Lander. 1992. A genetic map of the mouse suitable for typing intraspecific crosses. Genetics 131: 423-447.
33. Charlton, B., and T. E. Mandel. 1988. Progression from insulitis to β-cell destruction in NOD mouse requires L3T4+ T-lymphocytes. Diabetes 37: 1108-1112.
34. Cha, S., J. Brayer, J. Gao, V. Brown, S. Killedar, U. Yasunari, and A. B. Peck. 2004. A dual role for interferon-γ in the pathogenesis of Sjogren's syndrome-like autoimmune exocrinopathy in the nonobese diabetic mouse. Scand. J. Immunol. 60: 552-565.
35. Hesselstrand, R., A. Scheja, G. Q. Shen, A. Wiik, and A. Akesson. 2003. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford) 42: 534-540.
36. Toda, I., B. D. Sullivan, E. M. Rocha, L. A. Da Silveira, L. A. Wickham, and D. A. Sullivan. 1999. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome. Exp. Eye Res. 69: 355-366.
37. Boulard, O., D. Damotte, N. Deruytter, G. Fluteau, C. Carnaud, and H. J. Garchon. 2002. An interval tightly linked to but distinct from the H2 complex controls both overt diabetes (Idd16) and chronic experimental autoimmune thyroiditis (Ceat1) in nonobese diabetic mice. Diabetes 51: 2141-2147. (Pubitemid 34729019)
38. Fox, R. I. 2005. Sjögren's syndrome. Lancet 366: 321-331.
39. Hu, Y., Y. Nakagawa, K. R. Purushotham, and M. G. Humphreys-Beher. 1992. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263: E607-E614.
40. Humphreys-Beher, M. G., Y. Hu, Y. Nakagawa, P. L. Wang, and K. R. Purushotham. 1994. Utilization of the non-obese diabetic (NOD) mouse as an animal model for the study of secondary Sjögren's syndrome. Adv. Exp. Med. Biol. 350: 631-636.
41. Jonsson, M. V., N. Delaleu, K. A. Brokstad, E. Berggreen, and K. Skarstein. 2006. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 54: 2300-2305.
42. Rosignoli, F., V. Roca, R. Meiss, J. Leceta, R. P. Gomariz, and C. Pérez Leirós. 2005. Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis. Clin. Exp. Immunol. 142: 411-418.
43. Gao, J., S. Killedar, J. G. Cornelius, C. Nguyen, S. Cha, and A. B. Peck. 2006. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease. J. Autoimmun. 26: 90-103.
44. Robinson, C. P., S. Yamachika, D. I. Bounous, J. Brayer, R. Jonsson, R. Holmdahl, A. B. Peck, and M. G. Humphreys-Beher. 1998. A novel NOD-derived murine model of primary Sjögren's syndrome. Arthritis Rheum. 41: 150-156.
45. Nguyen, C., E. Singson, J. Y. Kim, J. G. Cornelius, R. Attia, M. E. Doyle, M. Bulosan, S. Cha, and A. B. Peck. 2006. Sjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus. Scand. J. Immunol. 64: 295-307.
46. Nguyen, C. Q., H. Kim, J. G. Cornelius, and A. B. Peck. 2007. Development of Sjogren's syndrome in nonobese diabetic-derived autoimmune-prone C57BL/6. NOD-Aec1Aec2 mice is dependent on complement component-3. J. Immunol. 179: 2318-2329.
47. Brodnicki, T. C., F. Quirk, and G. Morahan. 2003. A susceptibility allele from a non-diabetes-prone mouse strain accelerates diabetes in NOD congenic mice. Diabetes 52: 218-222.
48. Humphreys-Beher, M. G., L. Brinkley, K. R. Purushotham, P. L. Wang, Y. Nakagawa, D. Dusek, M. Kerr, N. Chegini, and E. K. Chan. 1993. Characterization of antinuclear autoantibodies present in the serum from nonobese diabetic (NOD) mice. Clin. Immunol. Immunopathol. 68: 350-356.
49. Baxter, A. G., D. Healey, and A. Cooke. 1994. Mycobacteria precipitate autoimmune rheumatic disease in NOD mice via an adjuvant-like activity. Scand. J. Immunol. 39: 602-606.
50. Hahn, B. H., and L. E. Shulman. 1969. Autoantibodies and nephritis in the white strain (NZW) of New Zealand mice. Arthritis Rheum. 12: 355-364.
51. Lambert, P. H., and F. J. Dixon. 1970. Genesis of antinuclear antibody in NZB-W mice: role of genetic factors and of viral infections. Clin. Exp. Immunol. 6: 829-839.
52. Nguyen, C. Q., S. R. Cha, and A. B. Peck. 2007. Sjögren's syndrome (SjS)-like disease of mice: the importance of B lymphocytes and autoantibodies. Front. Biosci. 12: 1767-1789.
53. Groom, J., S. L. Kalled, A. H. Cutler, C. Olson, S. A. Woodcock, P. Schneider, J. Tschopp, T. G. Cachero, M. Batten, J. Wheway, et al. 2002. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J. Clin. Invest. 109: 59-68.
54. Irie, J., Y. Wu, D. A. Sass, and W. M. Ridgway. 2006. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region. Immunogenetics 58: 9-14.
55. Morel, L., U. H. Rudofsky, J. A. Longmate, J. Schiffenbauer, and E. K. Wakeland. 1994. Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1: 219-229. (Pubitemid 124000704)
56. Liu, K., Q. Z. Li, Y. Yu, C. Liang, S. Subramanian, Z. Zeng, H. W. Wang, C. Xie, X. J. Zhou, C. Mohan, et al. 2007. Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun. 8: 634-645.
57. Helyer, B. J., and J. B. Howie. 1963. Renal disease associated with positive lupus erythematosus tests in a cross-bred strain of mice. Nature 197: 197.
58. Robinson, C. P., J. Brayer, S. Yamachika, T. R. Esch, A. B. Peck, C. A. Stewart, E. Peen, R. Jonsson, and M. G. Humphreys-Beher. 1998. Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome. Proc. Natl. Acad. Sci. U.S.A. 95: 7538-7543.
59. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
60. Silveira, P. A., J. Dombrowsky, E. Johnson, H. D. Chapman, D. Nemazee, and D. V. Serreze. 2004. B cell selection defects underlie the development of diabetogenic APCs in nonobese diabetic mice. J. Immunol. 172: 5086-5094.
61. Mariño, E., M. Batten, J. Groom, S. Walters, D. Liuwantara, F. Mackay, and S. T. Grey. 2008. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes 57: 395-404.
62. Serreze, D. V., C. M. Choisy-Rossi, A. E. Grier, T. M. Holl, H. D. Chapman, J. R. Gahagan, M. A. Osborne, W. Zhang, B. L. King, A. Brown, et al. 2008. Through regulation of TCR expression levels, an Idd7 region gene(s) interactively contributes to the impaired thymic deletion of autoreactive diabetogenic CD8+ T cells in nonobese diabetic mice. J. Immunol. 180: 3250-3259.